Kissei Pharmaceutical Co., Ltd.

Kissei Pharmaceutical Co., Ltd. logo
πŸ‡―πŸ‡΅Japan
Ownership
Public
Established
1946-08-09
Employees
1.7K
Market Cap
-
Website
http://www.kissei.co.jp

A Study of KCT-0809 in Patients With Dry Eye Syndromes

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-09-30
Last Posted Date
2011-07-04
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
160
Registration Number
NCT01211951
Locations
πŸ‡―πŸ‡΅

Japan, Tohoku, Kanto, Chubu, Kansai, Kyushu region, Japan

A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-10-29
Last Posted Date
2010-09-28
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
20
Registration Number
NCT01004016
Locations
πŸ‡―πŸ‡΅

Japan, Japan, Japan

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

First Posted Date
2009-10-29
Last Posted Date
2010-07-27
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
750
Registration Number
NCT01004315
Locations
πŸ‡―πŸ‡΅

Japan, Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan

Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Phase 3
Withdrawn
Conditions
Interventions
First Posted Date
2009-10-28
Last Posted Date
2010-07-27
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
100
Registration Number
NCT01003405
Locations
πŸ‡―πŸ‡΅

Japan, Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan

Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-03-18
Last Posted Date
2010-02-03
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
40
Registration Number
NCT00863538
Locations
πŸ‡―πŸ‡΅

Japan, Kanto Region, Japan

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-08-28
Last Posted Date
2009-09-04
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
400
Registration Number
NCT00742833
Locations
πŸ‡―πŸ‡΅

Japan, Tohoku region, Japan

Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-07-24
Last Posted Date
2009-03-18
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
80
Registration Number
NCT00721656
Locations
πŸ‡―πŸ‡΅

Japan, Shikoku region, Japan

Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients

Phase 3
Completed
Conditions
Interventions
First Posted Date
2007-04-18
Last Posted Date
2008-10-21
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Target Recruit Count
291
Registration Number
NCT00461617
Β© Copyright 2024. All Rights Reserved by MedPath